BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM;GLAXOSMITHKLINE INTELLECTUAL PROPERTY LIMITED;GLAXOSMITHKLINE INTELLECTUAL PROPERTY(NO.2) LIMITED
发明人:
申请号：
IL22737713
公开号：
IL227377D0
申请日:
2013.07.08
申请国别(地区):
IL
年份:
2013
代理人:
摘要：
The present invention relates to a method of treating ovarian cancer in a female human and to pharmaceutical combinations useful in such treatment. In particular, the method relates to a ovarian cancer treatment method that includes administering 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof, and 2-[(5-chloro-2-[[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino]-4-pyridinyl)amino]-N-methoxybenzamide, or a pharmaceutically acceptable salt thereof, and optionally 1,7beta,10beta-trihydroxy-9-oxo-5beta,20-epoxytax-11-ene-2alpha,4,13alpha-triyl 4-acetate 2-benzoate 13-{(2R,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}, to a human in need thereof.
